Yao Jun, Duan Ran, Li Qingyuan, Mo Ruonan, Zheng Pengcheng, Feng Tong
Respiratory and Critical Care Department, Guangyuan Central Hospital, Guangyuan, Sichuan, China.
Clinical Medical College, Chengdu Medical College, Chengdu, Sichuan, China.
Front Oncol. 2024 Jul 12;14:1346809. doi: 10.3389/fonc.2024.1346809. eCollection 2024.
Previous cohort studies conducted on large populations have suggested a potential association between obstructive sleep apnea (OSA) and an elevated risk of developing lung cancer. However, limited research has comprehensively investigated the correlation between the two conditions, and the causal effect remains unknown.
A comprehensive and systematic search was conducted across various databases, including PubMed, Web of Science, Cochrane Library, and Embase, from their inception dates to November 1, 2023. To assess the relationship between OSA and lung cancer, a meta-analysis was performed. Additionally, a two-sample Mendelian randomization (MR) study was conducted using summary data. The datasets included 336,659 individuals from the FinnGen study for OSA and 27,209 individuals from the International Lung Cancer Consortium study, as well as 420,473 individuals from the UK Biobank study for lung cancer. The estimates from each study were aggregated using the inverse variance-weighted method.
Data from six population-based cohort studies, encompassing 6,589,725 individuals, indicated a significant increase in the risk of developing lung cancer among patients with OSA (HR 1.28, 95% CI 1.07-1.54). However, the MR analysis did not support a causal relationship between OSA and lung cancer (OR 1.001, 95% CI 0.929-1.100). This lack of association was consistent across specific subtypes of lung cancer, including non-small-cell lung cancer (OR 1.000, 95% CI 0.999-1.000, p = 0.974), lung adenocarcinoma (OR 0.996, 95% CI 0.906-1.094, p = 0.927), and squamous cell lung carcinoma (OR 1.034, 95% CI 0.937-1.140, p = 0.507).
Our meta-analysis findings suggest an elevated risk of lung cancer among individuals with OSA. However, the MR analysis did not provide evidence supporting a causal relationship between OSA and lung cancer. Further investigation is required to uncover the underlying factors contributing to the observed association between OSA and lung cancer risk.
此前针对大量人群开展的队列研究表明,阻塞性睡眠呼吸暂停(OSA)与患肺癌风险升高之间可能存在关联。然而,仅有有限的研究全面调查了这两种情况之间的相关性,因果关系仍不明确。
对包括PubMed、Web of Science、Cochrane图书馆和Embase在内的多个数据库进行了全面系统的检索,检索时间跨度从各数据库建库之日至2023年11月1日。为评估OSA与肺癌之间的关系,进行了一项荟萃分析。此外,利用汇总数据开展了一项两样本孟德尔随机化(MR)研究。数据集包括来自芬兰基因研究(FinnGen study)的336,659名OSA患者、来自国际肺癌联盟研究(International Lung Cancer Consortium study)的27,209名个体,以及来自英国生物银行研究(UK Biobank study)的420,473名肺癌患者。每项研究的估计值采用逆方差加权法进行汇总。
来自六项基于人群的队列研究、涵盖6,589,725名个体的数据表明,OSA患者患肺癌的风险显著增加(风险比1.28,95%置信区间1.07 - 1.54)。然而,MR分析并不支持OSA与肺癌之间存在因果关系(比值比1.001,95%置信区间0.929 - 1.100)。这种缺乏关联的情况在肺癌的特定亚型中是一致的,包括非小细胞肺癌(比值比1.000,95%置信区间0.999 - 1.000,p = 0.974)、肺腺癌(比值比0.996,95%置信区间0.906 - 1.094,p = 0.927)和肺鳞状细胞癌(比值比1.034,95%置信区间0.937 - 1.140,p = 0.507)。
我们的荟萃分析结果表明,OSA患者患肺癌的风险升高。然而,MR分析并未提供支持OSA与肺癌之间存在因果关系的证据。需要进一步研究以揭示导致观察到的OSA与肺癌风险之间关联的潜在因素。